These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2116798)

  • 1. Phenotypic reversion of cisplatin resistance in human cells accompanies reduced host cell reactivation of damaged plasmid.
    Chao CC; Lee YL; Lin-Chao S
    Biochem Biophys Res Commun; 1990 Jul; 170(2):851-9. PubMed ID: 2116798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced host cell reactivation of damaged plasmid DNA in HeLa cells resistant to cis-diamminedichloroplatinum(II).
    Chao CC; Lee YL; Cheng PW; Lin-Chao S
    Cancer Res; 1991 Jan; 51(2):601-5. PubMed ID: 1898714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced excision repair of DNA damage due to cis-diamminedichloroplatinum(II) in resistant cervix carcinoma HeLa cells.
    Chao CC
    Eur J Pharmacol; 1994 Aug; 268(3):347-55. PubMed ID: 7805758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA repair in cells sensitive and resistant to cis-diamminedichloroplatinum(II): host cell reactivation of damaged plasmid DNA.
    Sheibani N; Jennerwein MM; Eastman A
    Biochemistry; 1989 Apr; 28(7):3120-4. PubMed ID: 2742829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host cell reactivation of cisplatin-damaged plasmid DNA in human non-T leukocyte cell lines.
    Dabholkar M; Reed E
    Cancer Lett; 1992 Apr; 63(2):143-50. PubMed ID: 1314131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host-cell reactivation of cisplatin-damaged pRSVcat in a human lymphoid cell line.
    Dabholkar M; Eastman A; Reed E
    Carcinogenesis; 1990 Oct; 11(10):1761-4. PubMed ID: 2170046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-resistance to UV radiation of a cisplatin-resistant human cell line: overexpression of cellular factors that recognize UV-modified DNA.
    Chao CC; Huang SL; Huang HM; Lin-Chao S
    Mol Cell Biol; 1991 Apr; 11(4):2075-80. PubMed ID: 2005898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of DNA repair in resistance of L1210 cells to isomeric 1,2-diaminocyclohexaneplatinum complexes and ultraviolet irradiation.
    Jennerwein MM; Eastman A; Khokhar AR
    Mutat Res; 1991 Jan; 254(1):89-96. PubMed ID: 1986276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of cisplatin sensitivity in non-malignant non-drug-selected human T cell lines.
    Dabholkar M; Parker R; Reed E
    Mutat Res; 1992 Jun; 274(1):45-56. PubMed ID: 1375331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in cervix carcinoma HeLa cells: relation to DNA repair.
    Chao CC
    Mol Pharmacol; 1994 Jun; 45(6):1137-44. PubMed ID: 8022407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated DNA repair capacity is associated with intrinsic resistance of lung cancer to chemotherapy.
    Zeng-Rong N; Paterson J; Alpert L; Tsao MS; Viallet J; Alaoui-Jamali MA
    Cancer Res; 1995 Nov; 55(21):4760-4. PubMed ID: 7585500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines.
    Masuda H; Ozols RF; Lai GM; Fojo A; Rothenberg M; Hamilton TC
    Cancer Res; 1988 Oct; 48(20):5713-6. PubMed ID: 3139281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatin.
    Cenni B; Kim HK; Bubley GJ; Aebi S; Fink D; Teicher BA; Howell SB; Christen RD
    Br J Cancer; 1999 May; 80(5-6):699-704. PubMed ID: 10360646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced repair of a cisplatin-damaged reporter chloramphenicol-O-acetyltransferase gene and altered activities of DNA polymerases alpha and beta, and DNA ligase in cells of a human malignant glioma following in vivo cisplatin therapy.
    Ali-Osman F; Berger MS; Rairkar A; Stein DE
    J Cell Biochem; 1994 Jan; 54(1):11-9. PubMed ID: 8126081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines.
    Lai GM; Ozols RF; Young RC; Hamilton TC
    J Natl Cancer Inst; 1989 Apr; 81(7):535-9. PubMed ID: 2493524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleotide excision repair in the human ovarian carcinoma cell line (2008) and its cisplatin-resistant variant (C13*).
    Moorehead RA; Armstrong SG; Rainbow AJ; Singh G
    Cancer Chemother Pharmacol; 1996; 38(3):245-53. PubMed ID: 8646799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repair of sulfur mustard-induced DNA damage in mammalian cells measured by a host cell reactivation assay.
    Matijasevic Z; Precopio ML; Snyder JE; Ludlum DB
    Carcinogenesis; 2001 Apr; 22(4):661-4. PubMed ID: 11285203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced nucleotide excision repair in cisplatin resistant human KB carcinoma cells.
    Mukai M; Kanzaki A; Chen ZS; Miyashita H; Sumizawa T; Furukawa T; Haraguchi M; Takebayashi Y; Takamatsu H; Akiyama S
    Oncol Rep; 2002; 9(4):839-44. PubMed ID: 12066219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation.
    Parker RJ; Eastman A; Bostick-Bruton F; Reed E
    J Clin Invest; 1991 Mar; 87(3):772-7. PubMed ID: 1999494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fotemustine, or etoposide.
    Rünger TM; Emmert S; Schadendorf D; Diem C; Epe B; Hellfritsch D
    J Invest Dermatol; 2000 Jan; 114(1):34-9. PubMed ID: 10620112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.